DIVERT: Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus (clinicaltrials.gov) - Sep 19, 2024 - P2 | N=9 | Terminated | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | N=120 ➔ 9 | Trial completion date: Jun 2026 ➔ Apr 2024 | Recruiting ➔ Terminated | Trial primary completion date: Jun 2025 ➔ Apr 2024; The study was closed due to slow enrollment.
Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|